Frontiers in Cancer Clinical Translation Seminar Series - December 5, 2023 @ Stanford Zoom
Title: “Regulatory Perspective on Diversity in Clinical Drug Development”   Presenter: Lola Fashoyin-Aje, MD, MPH Associate Director, Oncology Center of Excellence, and Deputy Clinical Division Director, Center for Drug Evaluation and Research, U.S. FDA,    
Stanford University's 5th Annual Neuromuscular Conference: Spinal Muscular Atrophy & Duchenne Muscular Dystrophy - Lessons Learned in Genetic Treatments @ Hybrid Event: Virtual or LKSC, Stanford, CA
‘ New advances in genetic treatments require continuing medical education for all clinicians caring for individuals with neuromuscular disorders to assure that all eligible patients receive treatments quickly, and to optimize outcomes. Genetic treatments, supplemental[...]
Frontiers in Cancer Clinical Translation Seminar Series - December 19, 2023 @ Stanford Zoom
Title: “The Journey of New Drugs (and People) in Industry” Presenter: Jane Huang, MD Adjunct Clinical Assistant Professor, President and Chief Medical Officer, Prelude Therapeutics, Medicine-Oncology, Stanford Health Care